Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-11-01

FDA Approved: OZEMPIC — Supplemental Application (Novo Nordisk)

View source ↗

Summary

FDA approved a supplemental application for Ozempic to expand its options by approving the oral semaglutide formulation for adults with type 2 diabetes mellitus…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OZEMPIC (semaglutide)

Snippet

SUPPL AP for OZEMPIC (ORAL SEMAGLUTIDE)